Clinical Alternatives for Reducing Harm Using E-cigarettes
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT07039292
- Status
- Enrolling By Invitation
Conditions
- E-Cig Use
- Oncology
- Smoking
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Harm Reduction (E-cigarette switching) — BEHAVIORALParticipants will be assigned to receive an e-cigarette and try to switch completely from smoking to using the e-cigarette
- Standard of Care — BEHAVIORALParticipants will be assigned to receive tobacco treatment referrals and the opportunity to re-enroll in the Tobacco Treatment Program
Study Details
For patients in cancer care, quitting smoking is critical, but a significant portion of patients in cancer care refuse all components of tobacco treatment, even when offered free of charge. The proposed clinical trial will assess one harm reduction intervention, switching completely from cigarettes to e-cigarettes, among oncology outpatients who smoke and refuse traditional tobacco treatment. This study is a type 1 hybrid effectiveness-implementation trial among oncology outpatients at an NCI-designated cancer center who smoke and refuse all components of tobacco treatment (N=208).
Key Dates
- Start date
- Aug 25, 2025
- Status verified
- May 2026
- Primary completion
- May 31, 2029
- Completion
- Nov 30, 2029
Study Design
- Enrollment
- 208 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Harm Reduction (E-cigarette switching)Participants will be assigned to receive an e-cigarette and try to switch completely from smoking to using the e-cigarette
- Active Comparator: Standard of CareParticipants will be assigned to receive tobacco treatment referrals and the opportunity to re-enroll in the Tobacco Treatment Program
Primary Outcome Measure
Complete switching [ Time Frame: 6 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 | - |
Find similar trials in Charleston, SC
By research site
Related Studies
- RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic ChemotherapyPHASE2 · Recruiting · The Hospital for Sick Children · San Francisco, California
- A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid RelapsePHASE2 · Recruiting · Eli Lilly and Company · Rogers, Arkansas
- Engaging Pharmacists to Advance Tobacco Treatment Service DeliveryEnrolling By Invitation · Medical University of South Carolina · Charleston, South Carolina
- Collection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesRecruiting · Weill Medical College of Cornell University · New York, New York